GSK3B and glioblastoma: We found that sortilin promoted GBM invasion via GSK-3β/β-catenin/Twist-induced mesenchymal transition, and that AF38469 could suppress GBM invasion and mesenchymal transition in vitro and in vivo (Fig. 7).